Eliot C. Williams, MD, PhD close
Eliot C. Williams, MD, PhD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Eliot C. Williams, MD, PhD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Eliot Williams, MD, PhD, is a long-standing member of the faculty of the Section of Hematology at the University of Wisconsin-Madison School of Medicine and Public Health. In conjunction with the other hematology physicians, Dr. Williams provides inpatient and outpatient care for hematology patients. He is currently serving as Section Head of Hematology. He has extensive expertise in clotting issues, including clotting disorders, thrombotic disorders, hypercoagulable disorders and recurrent venous thromboembolism.



Bleeding Disorders

Bone Marrow Biopsy

Hematology (Leukemia, Lymphoma and Multiple Myeloma)

Hematology (non cancer)


American Family Children's Hospital
(608) 890-9493 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
University Hospital
(608) 890-9493 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Hematology
Internal Medicine
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Internship University of Wisconsin Hospital and Clinics, Madison, WI
Medical School Indiana University School of Medicine, Indianapolis, IN

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Dr. Williams' research interests include bleeding and clotting disorders and leukemia.

PubMed Articles
Price TH Boeckh M Harrison RW McCullough J Ness PM Strauss RG Nichols WG Hamza TH Cushing MM King KE Young JA Williams E McFarland J Holter Chakrabarty J Sloan SR Friedman D Parekh S Sachais BS Kiss JE Assmann SF Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. Blood . 2015 Oct 29;126(18):2153-61
[PubMed ID: 26333778]
Medow JE Dierks MR Williams E Zacko JC The emergent reversal of coagulopathies encountered in neurosurgery and neurology: a technical note. Clin Med Res . 2015 Mar;13(1):20-31
[PubMed ID: 25380610]
Callander N Markovina S Eickhoff J Hutson P Campbell T Hematti P Go R Hegeman R Longo W Williams E Asimakopoulos F Miyamoto S Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network. Cancer Chemother Pharmacol . 2014 Oct;74(4):875-82
[PubMed ID: 25168296]
Micic D Williams EC Medow JE Cerebellar hemorrhage as a first presentation of acquired Hemophilia A. Neurocrit Care . 2011 Aug;15(1):170-4
[PubMed ID: 21713596]
O'Connor SD Taylor AJ Williams EC Winter TC Coagulation concepts update. AJR Am J Roentgenol . 2009 Dec;193(6):1656-64
[PubMed ID: 19933661]
Chang JE Medlin SC Kahl BS Longo WL Williams EC Lionberger J Kim K Kim J Esterberg E Juckett MB Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia. Leuk Lymphoma . 2008 Dec;49(12):2298-307
[PubMed ID: 19052977]
Young KH Zhang D Malik JT Williams EC Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy. Int J Clin Exp Pathol . 2008 Jan 1;1(2):185-97
[PubMed ID: 18784807]
Kujawski LA Longo WL Williams EC Turman NJ Brandt N Mosher DF Eickhoff JC Kahl BS A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas. Cancer Invest . 2007 Mar;25(2):87-93
[PubMed ID: 17453819]
Kahl BS Bailey HH Smith EP Turman N Smith J Werndli J Williams EC Longo WL Kim KM McGovern J Jumonville A Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study. Cancer Invest . 2005;23(1):13-8
[PubMed ID: 15779863]
Kobbervig C Williams E FXIII polymorphisms, fibrin clot structure and thrombotic risk. Biophys Chem . 2004 Dec 20;112(2-3):223-8
[PubMed ID: 15572253]
Warner TF Wrone DA Williams EC Cripps DJ Mundhenke C Friedl A Heparan sulphate proteoglycan in scleromyxedema promotes FGF-2 activity. Pathol Res Pract . 2002;198(10):701-7
[PubMed ID: 12498227]